NEWS
Takehiko Kaneko, CMO and Head of R&D at Heartseed, is speaking at this year's iPSC Manufacturing Summit in May 2-4.
Takehiko Kaneko, CMO and Head of R&D at Heartseed, is speaking at this year's iPSC Manufacturing Summit in May 2-4, presenting " Purification & Differentiation for Clinical Use of iPSC Derived Cardiomyocytes".
May 4, 9:00 am VIRTUAL Purification & Differentiation for Clinical Use of iPSC Derived Cardiomyocytes
Synopsis
- Achieving scalable method to eliminate undifferentiated cells and to reduce variability of product quality
- Managing efficient differentiation to assure clinical safety of the products
- Discovering new technology to generate high quality iPSCs with high differentiation potential